about
Sumatriptan (intranasal route of administration) for acute migraine attacks in adultsSumatriptan (subcutaneous route of administration) for acute migraine attacks in adultsDiclofenac with or without an antiemetic for acute migraine headaches in adultsSumatriptan (oral route of administration) for acute migraine attacks in adultsSumatriptan (rectal route of administration) for acute migraine attacks in adultsZolmitriptan for acute migraine headaches in adultsIbuprofen with or without an antiemetic for acute migraine headaches in adultsSumatriptan for acute migraine headaches in adultsDiclofenac with or without an antiemetic for acute migraine headaches in adultsSumatriptan (all routes of administration) for acute migraine attacks in adults: an overview of Cochrane reviewsSumatriptan plus naproxen for acute migraine headaches in adultsNaproxen with or without antiemetic for acute migraine headaches in adultsAspirin with or without an antiemetic for acute migraine headaches in adultsRizatriptan for acute migraine headaches in adultsParacetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adultsRizatriptan for acute migraine headaches in adultsCurrent Status of the New Antiepileptic Drugs in Chronic PainAcupuncture for recurrent headaches: a systematic review of randomized controlled trials.Migraine education improves quality of life in a primary care setting.Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neuronsA multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.A central analgesic mechanism of acupuncture for migraine: An ongoing functional MRI study.Eletriptan for acute migraine headaches in adults.Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons.Migraine: multiple processes, complex pathophysiology.Migraine headache misconceptions: barriers to effective care.Oral almotriptan: practical uses in the acute treatment of migraine.Botulinum toxin type A in chronic migraine.Transforming pain medicine: adapting to science and societyThe design and protocol of acupuncture for migraine prophylaxis: a multicenter randomized controlled trial.Economic evaluation of pharmacotherapy of migraine pain: a review of the literature.Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.Factors associated with emergency department visits for migraine: an observational study.Characterization and prediction of emergency department use in chronic daily headache patients.Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil.Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy.Patterns of specific antimigraine drug use--a study based on the records of 18 community pharmacies.Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries.The acute treatment of episodic and chronic migraine in the USA.
P2860
Q24203640-018529E6-3021-4698-95CA-19255BB748EAQ24203684-64A3FD55-31DC-45A4-BFE1-3E67158D1DADQ24203701-EC91415D-9B0D-434E-970C-30BC8240F404Q24203707-2F2AA440-D781-49EE-9B86-3F1C29E4F290Q24203726-12B1E4C1-A7D8-4A4B-8674-BB85DFDBD3FFQ24234412-C32F24DD-07D2-4991-8022-B74816EB62B1Q24234446-F142CE92-C74A-48AD-B9A2-5D6AEB0A76F3Q24234506-6C701B89-9B45-4CFE-8051-7CC486831D4AQ24234848-C4065571-0B6C-4673-B8D8-6DF6BC38F969Q24235029-068FEA2E-2572-4B4D-A27B-9E0877ED9D75Q24235044-1E41908D-C6A0-4A1A-A21F-90E718614478Q24235583-2F0B6769-ED0A-441F-B0DE-B4BB08A100E9Q24235987-1CD935A3-B684-423B-B429-1CCF7C336045Q24236184-7A4EFA40-B763-42E3-A45D-61255D3A3F68Q24236410-566EF256-70F6-4BE9-B0C4-83FAD37C9897Q26471366-B2EB392E-1831-4B45-B957-DEF59729008EQ28070254-F911513B-7EA0-441D-96E5-995DC237B838Q33792835-B1C7C1D9-8D5B-4AF7-8738-08F0B2ABCC0EQ33859925-7C47BCB0-0E06-42E6-B068-F51F6ED8D457Q33965206-8ACFD90D-FD1A-471E-9CCA-F82BD9E96063Q34003508-BD6579F9-2C27-4F94-9E3A-3ECF113C06CBQ34095112-ED891780-831E-453F-B109-7CCDA652D915Q34250923-A36470CE-B1F9-4698-B085-5ED0F3FC38A7Q35110517-B694142A-E599-4AA1-B581-F9657B1C2A16Q35547845-426FD153-585E-484D-8B47-C23DA6872A60Q35783724-5387F905-E063-41C9-9F3E-81162AF82978Q36106933-AB0BAF3A-775A-4654-9074-95D28DFEA51FQ36817036-CF79BEC0-F62A-4E60-BB7C-43C2AB4F0C86Q36926952-BFDD68FE-DF25-4770-B089-0E74C053275DQ37188797-218D3845-ADC5-4597-AF19-8574281896EBQ37641349-F2003E90-5B5C-4271-805F-B516CBF2EA92Q39407977-F072631C-C089-4AC1-B807-66B95C8DF71EQ40230589-4414D39D-08D4-4F98-AD93-76F28FB01D29Q40410185-A3AB4F8F-DFA4-44C6-98E8-E8451BEBC17CQ43989466-FEE58E73-553D-4721-BAE1-D875779498CAQ44295028-83D92202-220E-4973-AA90-99DF3FE96258Q44731908-D1D85285-E6EF-4D06-A38B-668E135689F8Q45249766-89DDFF55-FC21-4BB5-9E99-8DBC7B2BCE67Q45340852-4A14F983-A104-4CC8-A28B-36BD227F900CQ46053872-A2DAE074-E83B-4152-9251-3A15A96FDBF3
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The economic burden of migraine to society.
@ast
The economic burden of migraine to society.
@en
The economic burden of migraine to society.
@nl
type
label
The economic burden of migraine to society.
@ast
The economic burden of migraine to society.
@en
The economic burden of migraine to society.
@nl
prefLabel
The economic burden of migraine to society.
@ast
The economic burden of migraine to society.
@en
The economic burden of migraine to society.
@nl
P1433
P1476
The economic burden of migraine to society.
@en
P304
P356
10.2165/00019053-199813060-00003
P577
1998-06-01T00:00:00Z
P6179
1002674250